EP1864330A4 - Light as a replacement for mitrogenic factors on progenitor cells - Google Patents

Light as a replacement for mitrogenic factors on progenitor cells

Info

Publication number
EP1864330A4
EP1864330A4 EP06740014A EP06740014A EP1864330A4 EP 1864330 A4 EP1864330 A4 EP 1864330A4 EP 06740014 A EP06740014 A EP 06740014A EP 06740014 A EP06740014 A EP 06740014A EP 1864330 A4 EP1864330 A4 EP 1864330A4
Authority
EP
European Patent Office
Prior art keywords
mitrogenic
factors
replacement
light
progenitor cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP06740014A
Other languages
German (de)
French (fr)
Other versions
EP1864330B1 (en
EP1864330A2 (en
Inventor
Tara B Romanczyk
Juanita J Anders
Ronald W Waynant
Ilko Ilev
Leonardo Longo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Original Assignee
US Department of Health and Human Services
Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, Henry M Jackson Foundation for Advancedment of Military Medicine Inc filed Critical US Department of Health and Human Services
Priority to EP17201442.5A priority Critical patent/EP3329780A1/en
Priority to EP12159277.8A priority patent/EP2471368B1/en
Publication of EP1864330A2 publication Critical patent/EP1864330A2/en
Publication of EP1864330A4 publication Critical patent/EP1864330A4/en
Application granted granted Critical
Publication of EP1864330B1 publication Critical patent/EP1864330B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
EP06740014.3A 2005-03-31 2006-03-30 Light as a replacement for mitrogenic factors on progenitor cells Active EP1864330B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP17201442.5A EP3329780A1 (en) 2005-03-31 2006-03-30 Light as a replacement for mitogenic factors on progenitor cells
EP12159277.8A EP2471368B1 (en) 2005-03-31 2006-03-30 Light as a replacement for mitogenic factors on progenitor cells

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66658205P 2005-03-31 2005-03-31
US39170906A 2006-03-29 2006-03-29
PCT/US2006/011573 WO2006105254A2 (en) 2005-03-31 2006-03-30 Light as a replacement for mitrogenic factors on progenitor cells

Related Child Applications (3)

Application Number Title Priority Date Filing Date
EP17201442.5A Division EP3329780A1 (en) 2005-03-31 2006-03-30 Light as a replacement for mitogenic factors on progenitor cells
EP12159277.8A Division-Into EP2471368B1 (en) 2005-03-31 2006-03-30 Light as a replacement for mitogenic factors on progenitor cells
EP12159277.8A Division EP2471368B1 (en) 2005-03-31 2006-03-30 Light as a replacement for mitogenic factors on progenitor cells

Publications (3)

Publication Number Publication Date
EP1864330A2 EP1864330A2 (en) 2007-12-12
EP1864330A4 true EP1864330A4 (en) 2009-11-18
EP1864330B1 EP1864330B1 (en) 2016-10-19

Family

ID=37054113

Family Applications (3)

Application Number Title Priority Date Filing Date
EP17201442.5A Withdrawn EP3329780A1 (en) 2005-03-31 2006-03-30 Light as a replacement for mitogenic factors on progenitor cells
EP06740014.3A Active EP1864330B1 (en) 2005-03-31 2006-03-30 Light as a replacement for mitrogenic factors on progenitor cells
EP12159277.8A Active EP2471368B1 (en) 2005-03-31 2006-03-30 Light as a replacement for mitogenic factors on progenitor cells

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP17201442.5A Withdrawn EP3329780A1 (en) 2005-03-31 2006-03-30 Light as a replacement for mitogenic factors on progenitor cells

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP12159277.8A Active EP2471368B1 (en) 2005-03-31 2006-03-30 Light as a replacement for mitogenic factors on progenitor cells

Country Status (6)

Country Link
US (1) US9205276B2 (en)
EP (3) EP3329780A1 (en)
JP (2) JP2009506794A (en)
AU (1) AU2006230329C1 (en)
CA (1) CA2603443C (en)
WO (1) WO2006105254A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7534255B1 (en) 2003-01-24 2009-05-19 Photothera, Inc Low level light therapy for enhancement of neurologic function
US7303578B2 (en) 2001-11-01 2007-12-04 Photothera, Inc. Device and method for providing phototherapy to the brain
US10683494B2 (en) 2001-11-01 2020-06-16 Pthera LLC Enhanced stem cell therapy and stem cell production through the administration of low level light energy
US10695577B2 (en) 2001-12-21 2020-06-30 Photothera, Inc. Device and method for providing phototherapy to the heart
US7575589B2 (en) 2006-01-30 2009-08-18 Photothera, Inc. Light-emitting device and method for providing phototherapy to the brain
US7848035B2 (en) 2008-09-18 2010-12-07 Photothera, Inc. Single-use lens assembly
WO2013063389A2 (en) * 2011-10-26 2013-05-02 University Of Louisville Research Foundation, Inc. Methods and compositions for treating diabetes and other degenerative neuroendocrine diseases or disorders
CN103638604B (en) * 2012-12-31 2016-05-04 深圳先进技术研究院 A kind of walk help system
US9650608B2 (en) 2013-02-22 2017-05-16 Medivet America, Llc Activating adipose-derived stem cells for transplantation
JP6377929B2 (en) * 2014-03-27 2018-08-22 株式会社吉田製作所 Stem cell culture apparatus and stem cell culture method
EP3775908A1 (en) * 2018-04-13 2021-02-17 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting outcome and treatment of patients suffering from prostate cancer or breast cancer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6312451B1 (en) * 1999-03-23 2001-11-06 Jackson Streeter Low level laser therapy apparatus

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2637322A (en) * 1949-11-08 1953-05-05 Murray G Clay Apparatus for producing healthful sleep
KR100190423B1 (en) * 1989-06-06 1999-06-01 기타지마 요시도시 Apparatus for repairing defects in emulsion masks by passing laser light through a variable shaped aperture
US5989245A (en) * 1994-03-21 1999-11-23 Prescott; Marvin A. Method and apparatus for therapeutic laser treatment
US5626861A (en) * 1994-04-01 1997-05-06 Massachusetts Institute Of Technology Polymeric-hydroxyapatite bone composite
US5639402A (en) * 1994-08-08 1997-06-17 Barlow; Joel W. Method for fabricating artificial bone implant green parts
IL128115A (en) 1996-07-28 2005-06-19 Biosense Inc Electromagnetic cardia biostimulation
EP1073420A4 (en) * 1998-05-14 2004-09-08 Abraham Shahar Specially devised neuronal implants for reconstruction of damaged central nervous system
US6936044B2 (en) * 1998-11-30 2005-08-30 Light Bioscience, Llc Method and apparatus for the stimulation of hair growth
US6887260B1 (en) * 1998-11-30 2005-05-03 Light Bioscience, Llc Method and apparatus for acne treatment
US6471961B1 (en) * 1999-02-24 2002-10-29 Edward L. Tobinick Interleukin antagonists for the treatment of neurological, retinal and muscular disorders
US20010038836A1 (en) * 2000-04-04 2001-11-08 Matthew During Application of myeloid-origin cells to the nervous system
US20040266748A1 (en) * 2001-10-03 2004-12-30 Robinson Byron C Photosensitizing carbamate derivatives
US7303578B2 (en) * 2001-11-01 2007-12-04 Photothera, Inc. Device and method for providing phototherapy to the brain
AU2003216058A1 (en) 2002-01-14 2003-07-30 The Board Of Trustees Of The University Of Illinois Mammalian neural stem cells, compositions and uses thereof
US20040186087A1 (en) * 2003-03-20 2004-09-23 Ceramoptec Industries, Inc. Siderophore conjugates of photoactive dyes for photodynamic therapy
JP4564720B2 (en) * 2003-04-09 2010-10-20 菊治 山下 Incubator and cell culture method
US20050260710A1 (en) * 2004-03-31 2005-11-24 Sekisui Chemical Co. Ltd. Methods for producing recombinant polyclonal immunoglobulins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6312451B1 (en) * 1999-03-23 2001-11-06 Jackson Streeter Low level laser therapy apparatus

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
LINDVALL ET AL: "Prospects of transplantation in human neurodegenerative diseases", TRENDS IN NEUROSCIENCE, ELSEVIER, AMSTERDAM, NL, vol. 14, no. 8, 1 August 1991 (1991-08-01), pages 376 - 384, XP024352289, ISSN: 0166-2236, [retrieved on 19910801] *
MESTER A F ET AL: "PHOTOCHEMICAL EFFECTS OF LASER IRRADIATION ON NEURITIC OUTGROWTH OF OLFACTORY NEUROEPITHELIAL EXPLANTS", OTOLARYNGOLOGY AND HEAD AND NECK SURGERY, ROCHESTER, US, vol. 105, no. 3, 1 January 1991 (1991-01-01), pages 449 - 456, XP009123951, ISSN: 0194-5998 *
See also references of WO2006105254A2 *
SETOGUCHI T ET AL: "Treatment of spinal cord injury by transplantation of fetal neural precursor cells engineered to express BMP inhibitor", EXPERIMENTAL NEUROLOGY, ACADEMIC PRESS, NEW YORK, NY, US, vol. 189, no. 1, 1 September 2004 (2004-09-01), pages 33 - 44, XP004620695, ISSN: 0014-4886 *
WOLLMAN YORAM ET AL: "Low power laser irradiation enhances migration and neurite sprouting of cultured rat embryonal brain cells", NEUROLOGICAL RESEARCH, MANEY PUBLISHING, GB, vol. 18, no. 5, 1 January 1996 (1996-01-01), pages 467 - 470, XP009123934, ISSN: 0161-6412 *

Also Published As

Publication number Publication date
EP1864330B1 (en) 2016-10-19
WO2006105254A3 (en) 2009-05-07
US9205276B2 (en) 2015-12-08
CA2603443C (en) 2019-01-08
AU2006230329A1 (en) 2006-10-05
JP2013154224A (en) 2013-08-15
WO2006105254A2 (en) 2006-10-05
EP3329780A1 (en) 2018-06-06
JP2009506794A (en) 2009-02-19
EP2471368B1 (en) 2017-11-15
EP1864330A2 (en) 2007-12-12
CA2603443A1 (en) 2006-10-05
AU2006230329B2 (en) 2012-10-11
EP2471368A1 (en) 2012-07-04
AU2006230329C1 (en) 2013-03-14
US20100055074A1 (en) 2010-03-04

Similar Documents

Publication Publication Date Title
EP1864330A4 (en) Light as a replacement for mitrogenic factors on progenitor cells
ZA200802864B (en) Fuel cartridge for fuel cells
GB2424118B (en) Fuel cells
GB0506866D0 (en) A fuel cell arrangement
GB0618577D0 (en) A light
HK1147360A1 (en) Power supply for a data center
EP2153275A4 (en) Lamp-hiding assembly for a direct lit backlight
GB0606652D0 (en) A light
EP2146670A4 (en) Toric sulcus lens
EP1873853A4 (en) Fuel cell
EP1863112A4 (en) Fuel cell
GB0507673D0 (en) Support for a camera
EP1863113A4 (en) Fuel cell
EP1950827A4 (en) Fuel cell
EP1923943A4 (en) Component for constituting fuel cell
GB2427767B (en) Circuitry arrangements for operating light sources
EP1873855A4 (en) Fuel cell
EP1942542A4 (en) Fuel cell
EP1883128A4 (en) Fuel cell
EP1865568A4 (en) Fuel cell
GB2446046B (en) Self regenerating light
EP1885012A4 (en) Fuel cell
EP2234164A4 (en) Can type optical module
EP1869362A4 (en) Operation light
TWI347020B (en) Multi-wavelength light-emitting module

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20071017

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

RIN1 Information on inventor provided before grant (corrected)

Inventor name: LONGO, LEONARDO

Inventor name: ROMANCZYK, TARA, B.

Inventor name: WAYNANT, RONALD, R.

Inventor name: ANDERS, JUANITA, J.

Inventor name: ILEV, ILKO

DAX Request for extension of the european patent (deleted)
R17D Deferred search report published (corrected)

Effective date: 20090507

RIC1 Information provided on ipc code assigned before grant

Ipc: A01N 63/00 20060101AFI20090603BHEP

Ipc: A01N 65/00 20090101ALI20090603BHEP

Ipc: C12N 5/00 20060101ALI20090603BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20091021

17Q First examination report despatched

Effective date: 20100305

RIN1 Information on inventor provided before grant (corrected)

Inventor name: WAYNANT, RONALD, R.

Inventor name: ROMANCZYK, TARA, B.

Inventor name: ILEV, ILKO

Inventor name: ANDERS, JUANITA, J.

Inventor name: LONGO, LEONARDO

RIN1 Information on inventor provided before grant (corrected)

Inventor name: ILEV, ILKO

Inventor name: ROMANCZYK, TARA, B.

Inventor name: LONGO, LEONARDO

Inventor name: ANDERS, JUANITA, J.

Inventor name: WAYNANT, RONALD, W.

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20160407

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMEN

Owner name: SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SE

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 837526

Country of ref document: AT

Kind code of ref document: T

Effective date: 20161115

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602006050616

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161019

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 837526

Country of ref document: AT

Kind code of ref document: T

Effective date: 20161019

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 12

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170120

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161019

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161019

REG Reference to a national code

Ref country code: GB

Ref legal event code: S117

Free format text: REQUEST FILED; REQUEST FOR CORRECTION UNDER SECTION 117 FILED ON 21 MARCH 2017

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170220

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170219

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161019

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161019

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161019

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602006050616

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161019

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161019

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161019

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161019

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161019

REG Reference to a national code

Ref country code: GB

Ref legal event code: S117

Free format text: CORRECTIONS ALLOWED; REQUEST FOR CORRECTION UNDER SECTION 117 FILED ON 21 MARCH 2017 ALLOWED ON 24 JULY 2017

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170119

26N No opposition filed

Effective date: 20170720

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161019

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161019

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170330

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20190325

Year of fee payment: 14

Ref country code: IT

Payment date: 20190322

Year of fee payment: 14

Ref country code: DE

Payment date: 20190327

Year of fee payment: 14

Ref country code: IE

Payment date: 20190327

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20190222

Year of fee payment: 19

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20060330

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20190401

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20190404

Year of fee payment: 14

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20161019

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161019

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602006050616

Country of ref document: DE

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20200331

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200331

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200331

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200330

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201001

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200331

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200331

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20210806

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200330

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200331

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230530

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20240326

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20240327

Year of fee payment: 19